Literature DB >> 17635240

High levels of serum prostate-specific antigen due to PSA producing follicular non-Hodgkin's lymphoma.

Jan Jelrik Oosterheert1, Leo M Budel, Pieter Vos, Shulamiet Wittebol.   

Abstract

OBJECTIVE: Both carcinoma of the prostate and non-Hodgkin's lymphoma are common in elderly patients. Measurement of serum prostate-specific antigen (PSA) is a frequently used tool to diagnose and monitor prostate carcinoma and is generally specific for diseases of the prostate. CASE: We describe a 68-yr-old patient with voiding difficulties and high PSA levels, but without inflammatory or malignant changes upon multiple transrectal ultrasound guided prostate biopsies. Digital rectal examination was normal. Laboratory showed a strongly elevated PSA level (62 microg/L, Immulight 2000); DPC, USA). A CT-scan showed a retroperitoneal process with mass in the right pelvis and infiltration of the bladder wall, suggestive for metastatic prostate carcinoma. Surgical excision of an axillary lymph node set the diagnosis at a stage IV follicular lymphoma, Berard grade I to II in which the majority of neoplastic cells expressed PSA. After lymphoma-specific treatment, there was a positron emission tomography (PET) confirmed complete remission with normal PSA levels (6 microg/L), which still persists.
CONCLUSION: Although rare, high PSA levels can be due to the presence of non-Hodgkin's lymphoma. Such a diagnosis should be considered when patients present with lymphadenopathy other than regional prostatic lymphadenopathy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17635240     DOI: 10.1111/j.1600-0609.2007.00883.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  5 in total

1.  Primary Non-Hodgkin Lymphoma of Prostate: a Case Report.

Authors:  R B Nerli; Adarsh Sanikop; Manas Sharma; Priyeshkumar Patel; Ranjit Kangale; Shashank Patil; Shridhar C Ghagane; Murigendra B Hiremath; Neeraj S Dixit
Journal:  Indian J Surg Oncol       Date:  2020-08-31

Review 2.  Rituximab for treating CD20+ prostate cancer with generalized lymphadenopathy: a case report and review of the literature.

Authors:  Angus Dalgleish; Peter Featherstone; Viatcheslav Vlassov; Moshe Rogosnitzky
Journal:  Invest New Drugs       Date:  2014-01-18       Impact factor: 3.850

3.  Unexpected discovery of prostatic diffuse large B-cell lymphoma after thulium laser vaporization in a patient with Waldenstrom macroglobulinemia.

Authors:  Jialei Wang; Huilei Yan; Shuyan Tian; Lei Qin; Yunbo Ma
Journal:  Quant Imaging Med Surg       Date:  2022-01

4.  Successful treatment of concomitant metastatic prostate cancer and B-cell non-Hodgkin's lymphoma with R-EPOCH chemotherapy regimen and antiandrogen therapy.

Authors:  Fayez Hanna; Ajay Prakash; Ebony Allan; Alhossain A Khalafallah
Journal:  BMJ Case Rep       Date:  2018-03-16

5.  Primary lymphomas of the prostate: two case reports and a review of the literature.

Authors:  Chaojun Wang; Peng Jiang; Jun Li
Journal:  Contemp Oncol (Pozn)       Date:  2012-11-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.